Fate Therapeutics

FATE

Börsenwert 215 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Wellington Management Group Boston, Massachusetts	7,52 Mio. $	+7,54 Mio. $	+1.197.200	Neu
2	KCM 2 Kingdon Capital Management New York	5,41 Mio. $	+5,43 Mio. $	+861.802	Neu
3	3 OrbiMed New York	4,41 Mio. $	+4,42 Mio. $	+702.000	Neu
4	4 Farallon Capital Management San Francisco, California	3,42 Mio. $	+3,43 Mio. $	+544.243	Neu
5	5 Board of Trustees of The Leland Stanford Junior University Redwood City, California	1,91 Mio. $	+1,91 Mio. $	+303.538	Neu
6	6 Principal Financial Group Des Moines, Iowa	1,27 Mio. $	+1,27 Mio. $	+201.900	Neu
7	7 Goldman Sachs New York	257.000 $	+258.083 $	+40.991	Neu
8	8 Millennium Management New York	165.000 $	+164.964 $	+26.201	Neu
9	9 Vanguard Group Malvern, Pennsylvania	116.000 $	+116.642 $	+18.526	Neu
10	10 Deutsche Bank Frankfurt Am Main Ge, Germany	115.000 $	+116.478 $	+18.500	Neu
11	11 Tower Research Capital (TRC) New York	66.000 $	+65.738 $	+10.441	Neu
12	12 UBS Zurich, Switzerland	11.000 $	+10.810 $	+1.717	Neu
13	13 PNC Financial Services Group Pittsburgh, Pennsylvania	6.000 $	+6.296 $	+1.000	Neu
14	14 Bank of America Charlotte, North Carolina	6.000 $	+6.516 $	+1.035	Neu
15	15 American International Group New York	622 $	+623 $	+99	Neu
16	16 Citigroup New York	–	+296 $	+47	Neu